Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.welcuredrugs.com | |
Market Cap | 5.43 Cr. | |
Enterprise Value(EV) | 5.32 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.00 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
Industry PE | 49.08 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 1.05 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 3.82 | Calculated using Price: 4.02 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.35 Cr. | 13,512,100 Shares |
FaceValue | 10 | |
About Welcure Drugs & Pharmaceuticals Ltd. | ||
Welcure Drugs & Pharmaceuticals Ltd. (WDPL) was incorporated as a Public Limited Company under the Companies Act, 1956 on 4th June, 1992 and obtained the certificate of commencement of business on 19th June 1992. |
1 Day |
|
+1.02% |
1 Week |
|
+1.02% |
1 Month |
|
-2.45% |
3 Month |
|
-8.08% |
6 Month |
|
-13.29% |
1 Year |
|
-42.73% |
2 Year |
|
+59.20% |
5 Year |
|
+279.05% |
10 Year |
|
+142.68% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 108.61 | -65.80 | 17.83 | -49.46 | 131.74 | 29.03 | ||||
Return on Capital Employed (%) | 108.91 | -65.46 | 18.22 | -48.94 | 131.94 | 29.12 | ||||
Return on Assets (%) | 5.68 | 10.40 | 227.41 | 94.50 | -58.62 | 14.57 | -34.54 | 112.99 | 27.77 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Non Curr. Liab. | |||||||||||
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | ||||||
Minority Int. | |||||||||||
Equity & Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Non Curr. Assets | 0 | ||||||||||
Curr. Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Other Income | 0 | 0 | 0 | ||||||||
Total Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Interest | |||||||||||
Depreciation | |||||||||||
Taxation | |||||||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash Fr. Inv. | 0 | 0 | 0 | ||||||||
Cash Fr. Finan. | |||||||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Mon, 29 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance In pursuant to SEBI Circular No CIR/CFD/CMD 1/27/2019 dated February 08 2019 and Regulation 24A of SEBI (Listing Obligation and Disclosure Requirement) Regulation 2015 we are attaching herewith the Annual Secretarial Compliance Report of Welcure Drugs & Pharmaceuticals Ltd issued by M/s V Kumar & Associates Practicing Company Secretaries dated May 29th 2023 for the financial year ended 31st March 2023. |
Tue, 23 May 2023
Board Meeting Intimation for Prior Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 And Information Regarding Reopening Of Trading Window Of Equity Shares Of The Company WELCURE DRUGS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 inter alia to consider and approve With reference to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of Board of Directors of Welcure Drugs & Pharmaceuticals Limited will be held on Monday 29th May 2023 at 3:00 P.M. at the registered office of the company inter alia to transact the following matters:1. To consider and take on record the Audited Financial Results for Quarter & Year ended 31st March 2023.2. Any other business as may be considered necessary.We further wish to inform you that as per requirement the Trading Window of Equity Shares of the Company shall reopen on 1st June 2023. |
Sat, 13 May 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate In compliance with Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 and based on the intimation received from the Companys Registrar and Share Transfer Agents M/s. Link lntime India Private Limited we would like to inform regarding issue of duplicate shares certificates in lieu of lost share certificate(s) for the following shareholder (s):Date of receipt of intimation Folio No Name Certificate No. Distinctive No. No. of Shares Reason 12th May 2023 0041193 Chandeshwar Prasad Yadav 119661 13491901-13492000 100 Lost by Holder 119661 13493201- 13493300 100 119661 13493401- 13493500 100 119661 13493501- 13493600 100 119661 13493601- 13493700 100 The duplicate share certificate(s) will be issued to the shareholder(s) shortly |
Wed, 31 May 2023 |
|
|
|
|
|